CART19 cell and auto-HSCT
Weihong Chen06062018
Phase 1 mab active
Quick answer
CART19 cell and auto-HSCT for Leukemia, Lymphocytic, Acute, B-Cell is a Phase 1 program (mab) at Shenzhen Second People's Hospital with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Shenzhen Second People's Hospital
- Indication
- Leukemia, Lymphocytic, Acute, B-Cell
- Phase
- Phase 1
- Modality
- mab
- Status
- active